Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Index investing offers a straightforward path to retirement goals with broad market exposure and low costs. This intro explains why it often suits long-term planning and how to begin with simple steps.
21,933 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
When you’re limited to one AI stock, picking the right winner matters. This article breaks down the case for a single...
Investors are weighing Vistra Stock against a backdrop of AI energy demand and regulatory scrutiny. This guide breaks...
The market feels pricey, but bargains hide in plain sight. Here are three deeply undervalued stocks less than $100, p...
As 2026 unfolds, a value-led rotation is drawing fresh money into the Vanguard Value ETF (VTV). With inflation coolin...
A deep dive into MiB: Bill Gurley, Benchmark—how a pioneering VC built a team culture, backed Uber and other giants, ...
In May, Figma delivered a performance surge that surprised many investors. This article breaks down the key drivers b...
When a sports contract becomes a financial puzzle, you learn what to watch for in any investment. This piece breaks d...
Four-time Olympic gold medalist Mo Farah uses his life story to urge Gen Z to own their finances, blending grit with ...
A leading life sciences supplier has seen its stock fall sharply over the past year. At the same time, a hedge fund s...
Tilray is expanding beyond its home market, but the stock market isn’t fully pricing in that growth. This article bre...
When a large hedge fund reduces its Celcuity stake, markets pay attention. This article breaks down the move, what it...